BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7782017)

  • 1. [Preventing imminent amputation by regional hyperthermic fibrinolytic drug perfusion. An intraoperative procedure for reopening thrombosed arteries in extremities].
    Mumme A
    Fortschr Med; 1995 May; 113(13):196. PubMed ID: 7782017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regional hyperthermic fibrinolytic perfusion as ultima ratio in critical ischemia of the lower extremities].
    Mumme A; Maatz W; Walterbusch G
    Zentralbl Chir; 1996; 121(12):1069-75. PubMed ID: 9092231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local catheter thrombolysis].
    Fischer M
    Med Klin (Munich); 1993 Aug; 88(8):485-91. PubMed ID: 8413051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparin and plasminogen increase the thrombolytic potential in recanalization of peripheral arterial occlusions by local streptokinase].
    Poredos P; Videcnik V
    Vasa Suppl; 1992; 37():62-3. PubMed ID: 1481104
    [No Abstract]   [Full Text] [Related]  

  • 5. [Locoregional ultrahigh dosage fibrinolysis of deep leg vein thrombosis].
    Mumme A; Kemen M; Ernst R; Zumtobel V
    Vasa Suppl; 1991; 33():122-3. PubMed ID: 1788639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrograde intravenous perfusion as ultima ratio in potential amputation patients with peripheral arterial occlusive disease].
    Pöhlmann G; Reinhardt D; Grohmann G; Eidner G; Müller S
    Vasa; 1995; 24(3):275-81. PubMed ID: 7676739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the results of fibrinolytic treatment of acute ischemia of the leg caused by thrombosis in arteriosclerosis].
    Brykczyński M
    Ann Acad Med Stetin; 1989; 35():115-30. PubMed ID: 2639594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Edema caused by isolated hyperthermic perfusion of the extremities].
    Walther H
    Z Lymphol; 1990 Aug; 14(1):24-6. PubMed ID: 2238800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tissue plasminogen activator in an isolated extracorporeal circuit.
    Geier B; Grossefeld M; Barbera L; Mumme A
    J Vasc Surg; 2001 Jan; 33(1):165-9. PubMed ID: 11137937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
    Enevoldsen MT; Rørdam P; Schroeder TV
    Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
    Eigler FW; Krause U
    Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysis block technique. Local fibrinolytic treatment of venous and arterial occlusions].
    Heimig T; Martin M
    Wien Med Wochenschr; 1993; 143(7-8):185-6. PubMed ID: 8379172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraarterial thrombolytic therapy in obliterative thromboangiitis of the lower extremities].
    Gervaziev VB; Kolobova OI
    Khirurgiia (Mosk); 1993 Feb; (2):26-32. PubMed ID: 8084146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic treatment of acute ischemia of the limbs caused by arterial thrombosis].
    Kempf Z; Jarecka A; Ortyl W
    Pol Tyg Lek; 1982 Jul; 37(22):633-6. PubMed ID: 7177955
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immediate reocclusion of the infrapopliteal segment after thrombolysis in acute ischemia of the lower limb of the thrombotic nature].
    Belgrano EA; Nardella L; Palladino F
    Minerva Chir; 1995 Oct; 50(10):879-81. PubMed ID: 8684635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system.
    Zwaveling JH; Maring JK; Mulder AB; Bom VJ; van Ginkel RJ; Schraffordt Koops H; Girbes AR; Hoekstra HJ; van der Meer J
    Cancer Res; 1996 Sep; 56(17):3948-53. PubMed ID: 8752162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of fibrinolytic therapy in acute ischemia of the lower limbs].
    Bonelli U; Arnuzzo L; Cerruti R
    Minerva Cardioangiol; 1992; 40(1-2):41-6. PubMed ID: 1630669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benefit of one thrombolytic over another.
    Grobman BJ
    Circulation; 1997 Sep; 96(6):2093. PubMed ID: 9323115
    [No Abstract]   [Full Text] [Related]  

  • 20. [Portal vein thrombosis in protein C deficiency: successful fibrinolytic therapy with ultra-high dose streptokinase].
    Jäger D; Hüppe D; Weber A; Schwegler U; Barth J; Braun BE
    Med Klin (Munich); 1994 Aug; 89(8):453-5. PubMed ID: 7968877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.